These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25986591)

  • 21. Potential legal barriers to increasing CMS/FDA collaboration: the law of trade secrets and related considerations.
    Wang SS; Smith JJ
    Food Drug Law J; 2003; 58(4):613-27. PubMed ID: 15027453
    [No Abstract]   [Full Text] [Related]  

  • 22. Protecting essential information about genetic variants as trade secrets: a problem for public policy?
    Juergens AK; Francis LP
    J Law Biosci; 2018 Dec; 5(3):682-705. PubMed ID: 31143458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical and intellectual property in the biological sciences.
    Maher EA
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):263-7. PubMed ID: 9193780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical invention: transforming your idea into a product.
    Machan L
    Can Assoc Radiol J; 2008 Feb; 59(1):16-8. PubMed ID: 18386752
    [No Abstract]   [Full Text] [Related]  

  • 25. Beyond financial conflicts of interest: Institutional oversight of faculty consulting agreements at schools of medicine and public health.
    Mello MM; Murtagh L; Joffe S; Taylor PL; Greenberg Y; Campbell EG
    PLoS One; 2018; 13(10):e0203179. PubMed ID: 30372431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad.
    Luo J; Kesselheim AS
    AMA J Ethics; 2016 Jul; 18(7):727-35. PubMed ID: 27437823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metal 3D printing: Patent law, trade secrets, and additive manufacturing.
    Rimmer M
    Front Res Metr Anal; 2022; 7():958761. PubMed ID: 36118015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A concise framework to facilitate open COVID pledge of non-disclosed technologies: In terms of non-disclosed patent applications and trade secrets.
    Wang RL; Shen CL; Wu TC; Hsiao WW
    J Formos Med Assoc; 2022 Aug; 121(8):1425-1430. PubMed ID: 34756502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Balancing public health, trade and intellectual monopoly privileges: recent Australian IP legislation and the TPPA.
    Vines T; Crow K; Faunce T
    J Law Med; 2012 Dec; 20(2):280-94. PubMed ID: 23431847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The intellectual property cookbook: a guide for the novice health-care telemedicine provider working with industry.
    Beauregard D; Beauregard G
    J Telemed Telecare; 2000; 6 Suppl 1():S107-9. PubMed ID: 10793990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intellectual property conundrum for the biological sciences.
    Olds JL
    Anat Rec B New Anat; 2004 Mar; 277(1):5-9. PubMed ID: 15052648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The high price of "free" trade: U.S. trade agreements and access to medicines.
    Lopert R; Gleeson D
    J Law Med Ethics; 2013; 41(1):199-223. PubMed ID: 23581666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical patents and some international trade issues: Canada, the United States, and NAFTA.
    Tancer RS
    Clin Ther; 1993; 15(6):1177-84; discussion 1120. PubMed ID: 8111813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intellectual property. Device trade.
    Mathieson S
    Health Serv J; 2004 Jan; 114(5889):28-9. PubMed ID: 14733075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intellectual property and access to ART: unwise choice of terminology.
    Stallman R
    PLoS Med; 2006 Nov; 3(11):e509; author reply e510. PubMed ID: 17132062
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intellectual property rights and right of access to medicines].
    Velásquez G
    Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sponsored research agreements, university and government licensing, and clinical trial agreements: special contractual and intellectual property rights considerations.
    Somers JP
    J Biolaw Bus; 2003; 6(4):5-13. PubMed ID: 15072054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccines and IP Rights: A Multifaceted Relationship.
    Durell K
    Methods Mol Biol; 2016; 1404():791-811. PubMed ID: 27076338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intellectual property-The Foundation of Innovation: A scientist's guide to intellectual property.
    Poticha D; Duncan MW
    J Mass Spectrom; 2019 Mar; 54(3):288-300. PubMed ID: 30676684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.